VintaBio
VintaBio is paving the way for faster, more reliable gene therapy access for every patient in need.
$64M ·
Source: fundraisingfox.com
Funding history ↓Signals
X account@vinta_bio · created Apr 19, 2022 (4 years old) · 2 followers
Website registeredDec 4, 2019 (6 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Round | $64M | — | fundraisingfox.com |
Timeline
- X account created
- Website created
Founders and team
JS
Junwei Sun Co-founder & AdvisorLinkedIn · source: vintabio.comSZ
Shangzhen Zhou FounderDR
David Radspinner Chief Executive OfficerJK
Jennifer Kingsley Chief Commercial Officer
Investors
Companies like VintaBio
WWhiteLab Genomics$26M Series B+ · Oct 2026
RRemedium$10M Series A · Aug 2026
IImmitra Bio$2.97M Pre Seed · Jul 2026
LLatus Bio$97M Series A · May 2026
FFuse Vectors$5M Pre Seed · Feb 2025AAkamis Bio$60M Series A · Dec 2024
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/vintabio (get a free API key).